Anti-Alpha-actin(smooth muscle) antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | Alpha-actin(smooth muscle) |
| Immunogen: | This antibody is produced by immunizing mice with a synthetic peptide (KLH-coupled) corresponding to a region of alpha smooth muscle Actin. |
| Species immunized: | Mouse |
| Isotype: | IgG2b |
| Applications: | Western Blot (1:1000); Immunohistochemistry (1:200); Immunocytochemistry (1:200); Flow Cytometry |
| Reactivity: | Human, Mouse |
| Clonality (clone number): | Monoclonal, A5-E6 |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 2 mg/ml |
| Purity: | Protein A/G affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | a actin antibody |
| AAT6 antibody | |
| ACTA_HUMAN antibody | |
| ACTA2 antibody | |
| Actin alpha 2 smooth muscle aorta antibody | |
| Actin aortic smooth muscle antibody | |
| Actin, aortic smooth muscle antibody | |
| ACTSA antibody | |
| ACTVS antibody | |
| Alpha 2 actin antibody | |
| Alpha actin 2 antibody | |
| Alpha cardiac actin antibody | |
| Alpha-actin-2 antibody | |
| Cell growth inhibiting gene 46 protein antibody | |
| Cell growth-inhibiting gene 46 protein antibody | |
| GIG46 antibody | |
| Growth inhibiting gene 46 antibody | |
| MYMY5 antibody |
Target information
Actins are highly conserved proteins involved in cell motility, structure and integrity. Actin has been found to be expressed in at least six isomeric forms. It is expressed in heart and skeletal striated muscle tissue, and in certain smooth muscle tissues, regulating contractile potentials for these cells. It is also expressed in the cytoplasm of non-muscle cells, functioning to control cell structure and motility. Smooth muscle alpha actin is of further interest because it is one of a few genes whose expression is relatively restricted to vascular smooth muscle cells. Expression of smooth muscle alpha actin is regulated by hormones, cell proliferation, and altered by pathological conditions including oncogenic transformation and atherosclerosis.
Provider
Erpantech Laboratory